BRAIN Biotech AG
VC Fund
Zwingenberg, Germany
BRAIN Biotech AG is a VC fund in Zwingenberg focused on Medical and Biopharma. As industrial biotechnology specialists, BRAIN Biotech develops and produces enzymes, proteins, microbial production strains and bioactive natural products for industrial applications. In addition, the company´s innovative biosolutions help make industrial processes more sustainable. The company focuses on food & beverages, life science, andenvironmental topics. BRAIN Biotech AG is the parent company of the BRAIN Biotech Group and has been listed on the Prime Standard of the Frankfurt Stock Exchange since 9 February 2016 (ticker symbol: BNN).
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries BRAIN Biotech AG invests in
Stages BRAIN Biotech AG invests in
Countries BRAIN Biotech AG invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
|
|||
|
|
|||
Investment Focus
Industry
- Medical 1 (50%)
- Biopharma 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Erik de Vries
Sr Director Business Development
|
Sr Director Business Development | Total investments: 0 | Find email | |
|
Ludger Roedder
Chief Business Officer
|
Chief Business Officer | Total investments: 0 | Find email | |
|
Manfred Bender
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
SolasCure aims to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds. | $13.4M / Series B / Mar 27, 2023 | |
|
|
SolasCure aims to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds. | $20.8M / Series A / Aug 09, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does BRAIN Biotech AG invest in?
BRAIN Biotech AG invests primarily in Medical, Biopharma and Health Care startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BRAIN Biotech AG?
Public channels for BRAIN Biotech AG include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BRAIN Biotech AG?
The team at BRAIN Biotech AG includes Erik de Vries (Sr Director Business Development), Ludger Roedder (Chief Business Officer) and Manfred Bender (Chief Financial Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!